Skip to main content
SpringerLink
Log in

Regulatory Implications of Good Clinical Practice

Towards Harmonisation

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Allen ME, Vandenburg MJ. Good clinical practice: rules, regulations and their impact on the investigator. British Journal of Clinical Pharmacology 33: 463–465, 1992

    Article  PubMed  CAS  Google Scholar 

  • D’Arcy and Harron (Eds) Proceedings of The First International Conference on Harmonisation, Brussels 1991, The Queen’s University of Belfast, 1992

  • Faulds D, Lewis NJW, Milne RJ. Recombinant granulocyte colony-stimulating factor (rG-CSF). Pharmacoe-conomic considerations in chemotherapy-induced neutropenia. PharmacoEconomics 1: 231–249, 1992

    Article  PubMed  CAS  Google Scholar 

  • Gerlis L. Good clinical practice in clinical research. Lancet 1: 1008–1009, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hvidberg EF. Good clinical practice: a way to better drugs. British Medical Journal 299: 580–581, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hvidberg EF. In D’Arcy and Harron (Eds) Proceedings of The First International Conference on Harmonisation, Brussels 1991, pp. (470–471), The Queen’s University of Belfast, 1992

  • Idänpään-Heikkilä J. Role of the WHO in the harmonization of requirements for pharmaceutical products. In D’Arcy and Harron (Eds) Proceedings of The First International Conference on Harmonisation, Brussels 1991, pp. (27–28), The Queen’s University of Belfast, 1992

  • Kessler DA. The regulation of investigational drugs. New England Journal of Medicine 320: 281–288, 1989

    Article  PubMed  CAS  Google Scholar 

  • Leese B, Hutton J, Maynard A. A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countries. PharmacoEconomics 1: 346–356, 1992

    Article  PubMed  CAS  Google Scholar 

  • Maurice NP. Case studies. In D’Arcy and Harron (Eds) Proceedings of The First International Conference on Harmonisation, Brussels 1991, pp. (448–454), The Queen’s University of Belfast, 1992

  • Morice A. Good clinical practice and the clinical Pharmacologist. British Journal of Clinical Pharmacology 32: 529–530, 1991

    Article  PubMed  CAS  Google Scholar 

  • The Scrip Guide to Good Clinical Practice. Documenting clinical trials to US FDA requirements. PJB Publications Ltd, Richmond, England, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, University Hospital of Copenhagen, Copenhagen, Denmark

    Eigill F. Hvidberg

Authors
  1. Eigill F. Hvidberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hvidberg, E.F. Regulatory Implications of Good Clinical Practice. Drugs 45, 171–176 (1993). https://doi.org/10.2165/00003495-199345020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199345020-00002

Keywords

Search

Navigation